Ativos
Ativos
Ativos
®
Brightenyl
Skin complexion bioptimizer
Brightenyl® is the very first cosmetic active ingredient that is activated by a new
functional layer of the human skin: the stratum microbium™.
This new layer acts as an active living veil converting Brightenyl® in two molecules,
which act on seven biological targets to obtain a perfect skin complexion.
All skin types may experience color and pigmentation disorders. These include
discoloration marks, brown spots, redness as well as pigmented patches on skin.
Uneven skin color and tone give an unhealthy, dull and tired appearance. The ideal look
for healthy skin of any color is a clear even skin tone. Controlling the skin color, redness
and reducing pigmentation require the use of different ingredients as these parameters
rely on several different biological processes (vasodilation, inflammation, melanogenesis,
coagulation of melanin, accumulation of UV-induced damages…).
Our body lives in symbiosis with massive amounts of beneficial microorganisms, which
enable us to maintain our health on a daily basis. This micro-flora is called the human
microbiote. It accounts for almost ten times as many cells as in the rest of our body,
while representing orders of magnitude more genes than are contained in the human
genome.
The human skin being the largest exposed organ, is also one of the largest microbial
habitats. The human skin microbiote has a known symbiotic population from 100 to
more than 10,000,000 cells per cm2 depending on the body area1. The mutualistic
interaction between humans and skin microflora is a result of long co-evolutionary
processes involving the skin as the physical interface of our body with its outside
environment. The traditional microbiology-based methods do not offer a full access and
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1
Mathieu et al., 2013, Research in Microbiology
Induchem's R&D center, libragen, is one of the world’s leading centers in the
metagenomic technology. They have recently analyzed the human skin microbiote by
sampling the superficial layers of the skin of volunteers, and sequencing the genomes of
their stratum microbium. The analysis of 40 billions of DNA bases 3 has enabled to
discover that our skin microbiote possesses genes of alpha-glucosidases, highly selective
enzymes which could be used to activate cosmetic ingredients and increase their
efficacy on the skin.
Delivered in situ, THBA and THBG act in synergy on 7 biological targets to regulate and
optimize the skin complexion:
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2
Gao et al., 2007, PNAS!
3
!40 billions DNA bases reading = reading 160,000 books of 250 pages each, or reading twice the whole Wikipedia EN
content (9 millions articles)
BRIGHTENYL®&
UV$
THBA&
ROS$
THBG&
THBG&
Nf#kB&
DNA&&&
damages& Galactose&&receptor&
Melanosome& PGE2&
THBG&
THBA&
Tyrosinase&
MITF$
©&INDUCHEM&2015&
DERMIS&
The biological activity of Brightenyl® has been evaluated on a panel of Korean women
versus a placebo for a period of 84 days using 3 independent methodologies:
• Full face analysis with the Visia CR,
• Skin color measurement with a Chromameter, and
• Skin melanin content measure at specific sites with the Sciascope.
The volunteers have experienced a clear and visible evolution of the quality of their
complexion in 28 days, with long-term benefits after 84 days:
• 18 times decrease of the UV spots on their face
• -150% decrease of the melanin content of their hyperpigmented spots
• -600% decrease of the redness of their skin
• 16 times increase of the brightness of their skin
74% of the volunteers were satisfied by the results (brighter skin, less redness, less
hyperpigmentation disorders) and wanted to buy the prototype cream containing
Brightenyl®.
Skin tone uniformity and skin color optimization (including reduction of pigmented
spots) is among the highest consumers' demands worldwide. Up to now, the only
solutions to optimize skin complexion required several ingredients to deliver clinical
benefits. Brightenyl® is a S.M.A.R.T. (Skin-Melanin-Active-Removal-Technology)
ingredient. Far from probiotics, prebiotics and other traditional skin microflora
ingredients, it represents a new generation of multifunctional skin complexion
optimizing molecule, which is activated in situ by the living veil called the stratum
microbium.
Brightenyl® has been created according to the pharmaceutical development processes:
an active core (THBA) has been optimized by biotechnology process to generate a
stabilized and bioactivable compound through rational design. This compound has been
synthetized with cutting edge manufacturing processes, and further evaluated through
complete in vitro and ex vivo tests to understand its multiple modes of action. It has
then been tested on human skin in double blind versus placebo conditions under the
control of a dermatologist.
By targeting several biological pathways, Brightenyl® addresses all the different causes
of uneven skin tone, redness and pigmentation issues simultaneously.
Perfectly safe, it enables creation of new generation of products to enhance consumers'
beauty, and meet their expectations.
The synthesis of THBG relies on a pure enzymatic process that complies with the 12
rules of green chemistry. This process has been optimized to utilize water
only as a solvent and limit the over-usage of energy to manufacture a pure
stereospecific molecule in one step. The wastes of the synthesis are mainly
composed of water and a small fraction of unreacted THBA. THBG is
purified on a column to deliver a >95% pure molecule at the end of the
manufacturing process.
Brightenyl® has a light yellow color that does not impact the color of the finished
formula. Preservative free, odorless, water soluble and perfectly stable, Brightenyl ® is
compatible with all kind of cosmetic formulas containing water.
Brightenyl® allows the cosmetic industry to create a new generations of "perfect skin
tone and color" products, such as smooth whitening creams, intelligent brightening
serums, lightening lotions or sprays, CC creams (color correction creams), skin tone
enhancing gels, or anti-pigmented spots serums.
DISCLAIMER
Brightenyl® is a raw material ingredient for the manufacturing of finished cosmetic products. This information and all further technical
advice are based on our present knowledge and experience. However, it implies no liability or other legal responsibility on our part,
including with regard to existing third party intellectual property rights, especially patent rights. In particular, no warranty, whether express
or implied, or guarantee of product properties in the legal sense is intended or implied. We reserve the right to make any changes
according to technological progress or further developments. The customer is not released from the obligation to conduct careful
inspection and testing of incoming goods. Performance of the product described herein should be verified by testing, which should be
carried out only by qualified experts in the sole responsibility of a customer. Reference to trade names used by other companies is neither a
recommendation, nor does it imply that similar products could not be used.